期刊
JOURNAL OF HYPERTENSION
卷 27, 期 -, 页码 S36-S39出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.hjh.0000354519.67451.96
关键词
angiotensin receptor blockers; antihypertensive treatment; atrial fibrillation; blood pressure control; left ventricular hypertrophy; new-onset diabetes
Prevention of diabetes represents an important therapeutic goal in current cardiovascular risk reduction strategies. Blockade of the renin-angiotensin system has been shown to markedly reduce the incidence of new-onset diabetes in different patient populations. Recent results from three large clinical endpoint trials with the angiotensin-II receptor blocker telmisartan regarding new-onset diabetes, atrial fibrillation, and left ventricular hypotrophy will be discussed. J Hypertens 27 (suppl 2): S36-S39 (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据